Inventor Dr. Mehmet Ali SÖYLEMEZ discovered first time, the utility of the biomarker PROCALCITONIN in DIABETES MELLITUS. More than 47 publications have followed, substantiating PROCALCITONIN as one of the most promising biomarker tools for DIABETES MELLITUS of healthcare.

This invention is submitted a proposal for the LASKER AWARD 2024 and HARVARD MEDICAL SCHOOL ‘WARREN ALPERT PRIZE’ 2024. The inventor has also applied to the EUROPEAN INVENTOR AWARD 2024 with this invention.

This Invention receives WORLD’s Prestigious GHP– GLOBAL The HEALTHCARE and PHARMACEUTICAL Award Winner in 2023. This Invention also receives WORLD’s Prestigious ‘INNOVATION EXCELLENCE AWARD 2024‘. Please read the patent rights and the full patent.